Mesoblast
MESO
15 hedge funds and large institutions have $10.3M invested in Mesoblast in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 6 closing their positions.
12% less funds holding
Funds holding: 17 → 15 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
69% less capital invested
Capital invested by funds: $32.7M → $10.3M (-$22.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$1.74M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$970K |
| 3 |
PCMI
Princeton Capital Management Inc
Princeton,
New Jersey
|
+$452K |
| 4 |
Citigroup
New York
|
+$237K |
| 5 |
MMA
Miracle Mile Advisors
Los Angeles,
California
|
+$71.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.4M |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$431K |
| 3 |
Millennium Management
New York
|
-$175K |
| 4 |
Jane Street
New York
|
-$143K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$15K |
MESO Hedge Fund Activity: Q2 2016 in Review
15 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q2 2016, worth a combined $10.3M — down 69% from $32.7M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of MESO and 4 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $1.74M. The largest seller was Fidelity Investments, exiting entirely with an estimated $11.4M sold.
- 15 institutional investors held Mesoblast (MESO) as of Q2 2016, down from 17 in Q1 2016.
- Funds reported $10.3M of Mesoblast stock for Q2 2016, down 69% quarter-over-quarter.
- 4 funds opened new Mesoblast positions in Q2 2016 and 6 closed out, a net change of -2 holders.
- The largest Mesoblast buyer in Q2 2016 was Goldman Sachs, an estimated $1.74M added.
- The largest Mesoblast seller in Q2 2016 was Fidelity Investments, an estimated $11.4M sold.
Based on aggregated 13F filings for Q2 2016.